Literature DB >> 17827468

Single nucleotide polymorphisms in ABCG5 and ABCG8 are associated with changes in cholesterol metabolism during weight loss.

Sylvia Santosa1, Isabelle Demonty, Alice H Lichtenstein, Jose M Ordovas, Peter J H Jones.   

Abstract

The purpose of this study was to examine whether changes in cholesterol metabolism after weight loss were affected by single nucleotide polymorphisms (SNPs) in ABCG5 and ABCG8 genes. Thirty-five hypercholesterolemic women lost 11.7 +/- 2.5 kg (P < 0.001). Cholesterol kinetics were assessed using stable isotope techniques. TaqMan PCR was used to detect SNPs in ABCG5/G8. Homozygous Q604E variants in ABCG5 had larger (P < 0.05) reductions in cholesterol absorption and greater increases (P < 0.05) in synthesis in contrast to heterozygous and homozygous wild-type carriers. Heterozygous C54Y carriers had smaller declines (P = 0.047) in synthesis compared with homozygous variant individuals. The presence of at least one Y54 variant was associated with higher (P = 0.042) post-weight-loss synthesis compared with carriers of the C54 genotype. The direction of the results is consistent with cross-sectional studies on the effects of Q604E and C54Y polymorphisms on plasma cholesterol. SNPs in ABCG5/G8 were found to be associated with the response of cholesterol metabolism to weight loss. The evidence for associations between SNPs in ABCG5/G8 and various parameters of cholesterol metabolism indicates the potential effectiveness of establishing genetic screening tools to determine optimal lipid-lowering treatment routes for individuals during weight reduction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827468     DOI: 10.1194/jlr.M600452-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

Review 1.  ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis.

Authors:  Lily Jakulj; Maud N Vissers; Michael W T Tanck; Barbara A Hutten; Frans Stellaard; John J P Kastelein; Geesje M Dallinga-Thie
Journal:  J Lipid Res       Date:  2010-06-25       Impact factor: 5.922

2.  Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia.

Authors:  A Garcia-Rios; P Perez-Martinez; F Fuentes; P Mata; J Lopez-Miranda; R Alonso; F Rodriguez; A Garcia-Olid; J Ruano; J M Ordovas; F Perez-Jimenez
Journal:  Atherosclerosis       Date:  2010-01-22       Impact factor: 5.162

Review 3.  Effects of adiposity on plasma lipid response to reductions in dietary saturated fatty acids and cholesterol.

Authors:  Michael R Flock; Michael H Green; Penny M Kris-Etherton
Journal:  Adv Nutr       Date:  2011-04-30       Impact factor: 8.701

4.  Cholesterol absorption status and fasting plasma cholesterol are modulated by the microsomal triacylglycerol transfer protein -493 G/T polymorphism and the usual diet in women.

Authors:  Estelle Wolff; Marie-France Vergnes; Catherine Defoort; Richard Planells; Henri Portugal; Alain Nicolay; Denis Lairon
Journal:  Genes Nutr       Date:  2010-04-01       Impact factor: 5.523

5.  Plant sterols and stanols: their role in health and disease.

Authors:  Shailendra B Patel
Journal:  J Clin Lipidol       Date:  2008-04       Impact factor: 4.766

6.  The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study.

Authors:  Mireia Junyent; Katherine L Tucker; Caren E Smith; Antonio Garcia-Rios; Josiemer Mattei; Chao-Qiang Lai; Laurence D Parnell; Jose M Ordovas
Journal:  J Lipid Res       Date:  2008-11-12       Impact factor: 5.922

Review 7.  The ABCG5 ABCG8 sterol transporter and phytosterols: implications for cardiometabolic disease.

Authors:  Nadezhda S Sabeva; Jingjing Liu; Gregory A Graf
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

8.  The chylomicron: relationship to atherosclerosis.

Authors:  Gerald H Tomkin; Daphne Owens
Journal:  Int J Vasc Med       Date:  2011-10-05

9.  ATP-binding cassette transporter G5 and G8 polymorphisms and several environmental factors with serum lipid levels.

Authors:  Qing Li; Rui-Xing Yin; Xian-Liang Wei; Ting-Ting Yan; Lynn Htet Htet Aung; Dong-Feng Wu; Jin-Zhen Wu; Wei-Xiong Lin; Cheng-Wu Liu; Shang-Ling Pan
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

10.  Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.

Authors:  Yingying Zhang; Xin Liu; Liwen Liu; Jianan Chen; Qiuyue Hu; Shen Shen; Yongjian Zhou; Siyu Chen; Chen Xue; Guangying Cui; Zujiang Yu
Journal:  Dis Markers       Date:  2020-01-13       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.